These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 34205554

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    Anderson M, Panteli D, Mossialos E.
    ; 2023. PubMed ID: 37582187
    [Abstract] [Full Text] [Related]

  • 3. Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally.
    Vogler S, Habimana K, Haasis MA, Fischer S.
    Appl Health Econ Health Policy; 2024 Sep; 22(5):629-652. PubMed ID: 38837100
    [Abstract] [Full Text] [Related]

  • 4. Encouraging the Development of New Antibiotics: Are Financial Incentives the Right Way Forward? A Systematic Review and Case Study.
    Dutescu IA, Hillier SA.
    Infect Drug Resist; 2021 Sep; 14():415-434. PubMed ID: 33574682
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. New business models for antibiotic innovation.
    So AD, Shah TA.
    Ups J Med Sci; 2014 May; 119(2):176-80. PubMed ID: 24646116
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Repairing the broken market for antibiotic innovation.
    Outterson K, Powers JH, Daniel GW, McClellan MB.
    Health Aff (Millwood); 2015 Feb; 34(2):277-85. PubMed ID: 25646108
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps.
    Simpkin VL, Renwick MJ, Kelly R, Mossialos E.
    J Antibiot (Tokyo); 2017 Dec; 70(12):1087-1096. PubMed ID: 29089600
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Linking Sustainable Use Policies to Novel Economic Incentives to Stimulate Antibiotic Research and Development.
    Theuretzbacher U, Årdal C, Harbarth S.
    Infect Dis Rep; 2017 Mar 30; 9(1):6836. PubMed ID: 28458797
    [Abstract] [Full Text] [Related]

  • 13. Exploring the Obstacles to Implementing Economic Mechanisms to Stimulate Antibiotic Research and Development: A Multi-Actor and System-Level Analysis.
    Baraldi E, Ciabuschi F, Leach R, Morel CM, Waluszewski A.
    Am J Law Med; 2016 May 30; 42(2-3):451-486. PubMed ID: 29086643
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    Lavis JN, Permanand G, Catallo C, BRIDGE Study Team, WHO Regional Office for Europe and European Observatory on Health Systems and Policies.
    ; 2013 May 30. PubMed ID: 29155540
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Paving the Way for the Implementation of a Decision Support System for Antibiotic Prescribing in Primary Care in West Africa: Preimplementation and Co-Design Workshop With Physicians.
    Peiffer-Smadja N, Poda A, Ouedraogo AS, Guiard-Schmid JB, Delory T, Le Bel J, Bouvet E, Lariven S, Jeanmougin P, Ahmad R, Lescure FX.
    J Med Internet Res; 2020 Jul 20; 22(7):e17940. PubMed ID: 32442155
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antibiotic innovation for future public health needs.
    Theuretzbacher U.
    Clin Microbiol Infect; 2017 Oct 20; 23(10):713-717. PubMed ID: 28652114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.